Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals board to consider unaudited financial statements

18 Jan 2013 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on January 29, 2013, to consider and approve the company’s un-audited financial statements for the Third Quarter ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..